[go: up one dir, main page]

NO996234L - Sprayformuleringer av antihyperalgesiske opiater og fremgangsmåte for behandling av topiske hyperalgesiske forhold og kløe med disse - Google Patents

Sprayformuleringer av antihyperalgesiske opiater og fremgangsmåte for behandling av topiske hyperalgesiske forhold og kløe med disse

Info

Publication number
NO996234L
NO996234L NO996234A NO996234A NO996234L NO 996234 L NO996234 L NO 996234L NO 996234 A NO996234 A NO 996234A NO 996234 A NO996234 A NO 996234A NO 996234 L NO996234 L NO 996234L
Authority
NO
Norway
Prior art keywords
itching
therewith
methods
spray formulations
treating topical
Prior art date
Application number
NO996234A
Other languages
English (en)
Norwegian (no)
Other versions
NO996234D0 (no
Inventor
John J Farrar
An-Chih Chang
Alan L Maycock
Imre Balogh
Original Assignee
Adolor Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adolor Corp filed Critical Adolor Corp
Publication of NO996234D0 publication Critical patent/NO996234D0/no
Publication of NO996234L publication Critical patent/NO996234L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO996234A 1997-07-14 1999-12-16 Sprayformuleringer av antihyperalgesiske opiater og fremgangsmåte for behandling av topiske hyperalgesiske forhold og kløe med disse NO996234L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/892,389 US5798093A (en) 1997-03-14 1997-07-14 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith
PCT/US1998/012832 WO1999003457A1 (en) 1997-07-14 1998-06-19 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith

Publications (2)

Publication Number Publication Date
NO996234D0 NO996234D0 (no) 1999-12-16
NO996234L true NO996234L (no) 2000-03-10

Family

ID=25399881

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996234A NO996234L (no) 1997-07-14 1999-12-16 Sprayformuleringer av antihyperalgesiske opiater og fremgangsmåte for behandling av topiske hyperalgesiske forhold og kløe med disse

Country Status (9)

Country Link
US (1) US5798093A (pt)
EP (1) EP1011647A4 (pt)
JP (1) JP2001510153A (pt)
KR (1) KR20010021851A (pt)
AU (1) AU724727B2 (pt)
BR (1) BR9810711A (pt)
CA (1) CA2288132A1 (pt)
NO (1) NO996234L (pt)
WO (1) WO1999003457A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190691B1 (en) 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US6353004B1 (en) * 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
US6117904A (en) * 1999-09-03 2000-09-12 Murphy; Donald M. Treatment of pruritus
US6541517B1 (en) 1999-09-03 2003-04-01 Donald M. Murphy Treatment of skin disorders
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
US6638981B2 (en) 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
TWI250023B (en) * 2001-10-22 2006-03-01 Santen Pharmaceutical Co Ltd Pharmaceutical composition for itch treating agent
MXPA05012007A (es) * 2003-05-08 2006-05-31 Kyorin Seiyaku Kk Compuesto de 4- (2-furoil) aminopiperidina util como agente terapeutico para el prurito.
ES2398740T3 (es) * 2006-12-28 2013-03-21 Institut Univ. De Ciència I Tecnologia, S.A. Proceso para la preparación de pimozide
FR2915097B1 (fr) * 2007-04-18 2012-09-28 Fabre Pierre Dermo Cosmetique Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617282A1 (de) * 1965-11-30 1975-02-06 Astra Pharma Prod Vorrichtung zur lokalanaesthetisierung durch oertliche aufbringung und verfahren zur herstellung dieser vorrichtung
US3624224A (en) * 1969-12-22 1971-11-30 Schering Corp Novel first aid products
US3884916A (en) * 1971-03-30 1975-05-20 Janssen Pharmaceutica Nv 2,2-Diaryl-4-(4-aryl-4-hydroxy-piperidino)-butyramides
US3714159A (en) * 1971-03-30 1973-01-30 Janssen Pharmaceutica Nv 2,2-diaryl-4-(4'-aryl-4'-hydroxy-piper-idino)-butyramides
US5035883A (en) * 1988-09-02 1991-07-30 Albert L. Jacobs Composition and method for treating human disorders susceptible to antimicrobial treatment
US5116847A (en) * 1991-01-25 1992-05-26 The Procter & Gamble Company Use of loperamide and related compounds for treatment of respiratory disease symptoms
WO1995027510A1 (en) * 1994-04-12 1995-10-19 Alza Corporation Screening methods for integumental inflammation modulating agents
US5516808A (en) * 1994-10-27 1996-05-14 Sawaya; Assad S. Topical cellulose pharmaceutical formulation
US5576346A (en) * 1995-04-03 1996-11-19 Ascent Pharmaceuticals, Inc. Process for treating uremic pruritus
US5667773A (en) * 1996-03-12 1997-09-16 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith

Also Published As

Publication number Publication date
EP1011647A1 (en) 2000-06-28
US5798093A (en) 1998-08-25
BR9810711A (pt) 2000-08-08
AU8074898A (en) 1999-02-10
NO996234D0 (no) 1999-12-16
AU724727B2 (en) 2000-09-28
KR20010021851A (ko) 2001-03-15
CA2288132A1 (en) 1999-01-28
EP1011647A4 (en) 2001-05-16
JP2001510153A (ja) 2001-07-31
WO1999003457A1 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
FI971412L (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä
NO20003096L (no) Sammensetninger og fremgangsmÕter for behandling av ADD
NO996352L (no) Kappaagonistforbindelser, farmasøytiske formuleringer og metode for forhindring og behandling av kløe med disse
NO996234L (no) Sprayformuleringer av antihyperalgesiske opiater og fremgangsmåte for behandling av topiske hyperalgesiske forhold og kløe med disse
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
ID30322A (id) HETEROSIKLIK YANG MENGANDUNG INHIBITOR BIFENIL aP2 DAN METODANYA
EP0925046A4 (en) TOPICAL PREPARATIONS AND METHODS FOR TREATING HEMORRHOIDS
DE69913530D1 (de) Benzothiepinen mit wirkung als inhibitoren des ileumgallensäuretransports und der taurocholate-aufnahme
ID17156A (id) Zat-zat anti koagulan yang berguna dalam pengobatan trombosis
EP1540126A4 (en) SHIELD HYDRATING DETERGENT AND METHOD OF USE
NO975759D0 (no) Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel
NO20004098L (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
EP1009404A4 (en) PROCESS FOR TREATING INFLAMMATION OR INFLAMMATORY DISEASES USING POLY-ADP RIBOSE POLYMERASE INHIBITORS
NO972125D0 (no) Hemmoroideblandinger og fremgangsmåte for anvendelse
NO20015274L (no) ACE-2 inhiberende forbindelser og fremgangsmåter for anvendelse derav
FI970317A7 (fi) Antiproliferatiivisina aineina ja Garft-inhibiittoreina käyttökelpoisia yhdisteitä
ATE267196T1 (de) Sulfonylbenzolverbindungen als analgetische und entzündungshemmende mittel
NO996351L (no) Filmdannende komposisjoner av antihyperalgesiske opiater og metode for behandling av hyperalgesiske og kløetilstander med disse
EP0994707A4 (en) INHIBITORS OF NAALADASE ENZYME ACTIVITY
PL339836A1 (en) Phtalazine compounds and therapeutic agents suitable to treat erection disorders
ID28368A (id) Tanda-tanda mikrosatelite tumbuhan dan metode terhadap penggunaannya
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
DE69731574D1 (de) Kompiliergerät und -verfahren
DE69713442D1 (de) Thioürazil-Derivate und diese enthaltende Metall-Oberflächebehandlungsmittel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application